250 related articles for article (PubMed ID: 32703679)
1. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
[TBL] [Abstract][Full Text] [Related]
2. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.
Shariq OA; Lines KE; English KA; Jafar-Mohammadi B; Prentice P; Casey R; Challis BG; Selberherr A; Boon H; Cranston T; Ryan FJ; Mihai R; Healy U; Kurzawinski T; Dattani MT; Bancos I; Dy BM; Lyden ML; Young WF; McKenzie TJ; Richards D; Thakker RV
Surgery; 2022 Jan; 171(1):77-87. PubMed ID: 34183184
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
8. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
[TBL] [Abstract][Full Text] [Related]
10. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
[TBL] [Abstract][Full Text] [Related]
12. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
13. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Vialon M; Desailloud R; Caron P
Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S19-S28. PubMed ID: 31606058
[TBL] [Abstract][Full Text] [Related]
15. Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.
Horiuchi K; Okamoto T; Iihara M; Tsukada T
Surg Today; 2013 Aug; 43(8):894-9. PubMed ID: 23052745
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
17. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.
Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML
Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
[TBL] [Abstract][Full Text] [Related]
19. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
Ramamoorthy B; Nilubol N
Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
[TBL] [Abstract][Full Text] [Related]
20. Update on the Genetics of Pituitary Tumors.
Barry S; Korbonits M
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):433-452. PubMed ID: 32741481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
